A Study of Therapeutic Iobenguane (131-I) for Relapsed, High-Risk Neuroblastoma Subjects (OPTIMUM)

The purpose of this study is to evaluate the efficacy and safety of 131I-MIBG in patients with neuroblastoma, who relapsed.

NCT: NCT03561259

Locations: University of Iowa Hospitals and Clinics, University of Chicago Medical Center    

Link: https://clinicaltrials.gov/ct2/show/NCT03561259?recrs=ad&cond=Neuroblastoma&locn=University+of+Iowa&cntry=US&age=0&draw=2&rank=11